277 related articles for article (PubMed ID: 24682000)
21. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD.
Bralten J; Franke B; Waldman I; Rommelse N; Hartman C; Asherson P; Banaschewski T; Ebstein RP; Gill M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant JA; Oosterlaan J; Sonuga-Barke E; Steinhausen HC; Faraone SV; Buitelaar JK; Arias-Vásquez A
J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1204-1212.e1. PubMed ID: 24157394
[TBL] [Abstract][Full Text] [Related]
22. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
Escobar R; Hervas A; Soutullo C; Mardomingo MJ; Uruñuela A; Gilaberte I
Actas Esp Psiquiatr; 2008; 36(5):285-94. PubMed ID: 18830848
[TBL] [Abstract][Full Text] [Related]
23. Open-label, dose-titration tolerability study of atomoxetine hydrochloride in Korean, Chinese, and Taiwanese adults with attention-deficit/hyperactivity disorder.
Takahashi M; Goto T; Takita Y; Chung SK; Wang Y; Gau SS
Asia Pac Psychiatry; 2014 Mar; 6(1):62-70. PubMed ID: 23857916
[TBL] [Abstract][Full Text] [Related]
24. Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial.
Amiri S; Mohammadi MR; Mohammadi M; Nouroozinejad GH; Kahbazi M; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):145-9. PubMed ID: 17765380
[TBL] [Abstract][Full Text] [Related]
25. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
[TBL] [Abstract][Full Text] [Related]
26. Is there a relationship between attention deficit/hyperactivity disorder and manic symptoms among children with mental retardation of unknown etiology?
Fidan T; Kirpinar I; Oral M; Koçak K
Compr Psychiatry; 2011; 52(6):644-9. PubMed ID: 21310401
[TBL] [Abstract][Full Text] [Related]
27. Comorbid symptom severity in attention-deficit/hyperactivity disorder: a clinical study.
Connor DF; Ford JD
J Clin Psychiatry; 2012 May; 73(5):711-7. PubMed ID: 22697195
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
Mohammadi MR; Kashani L; Akhondzadeh S; Izadian ES; Ohadinia S
J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
[TBL] [Abstract][Full Text] [Related]
29. Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder.
Weiss MD; Gibbins C; Goodman DW; Hodgkins PS; Landgraf JM; Faraone SV
J Clin Psychiatry; 2010 Apr; 71(4):381-90. PubMed ID: 20361900
[TBL] [Abstract][Full Text] [Related]
30. Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder.
Ratner S; Laor N; Bronstein Y; Weizman A; Toren P
J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):428-33. PubMed ID: 15843764
[TBL] [Abstract][Full Text] [Related]
31. Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity.
Ginsberg L; Katic A; Adeyi B; Dirks B; Babcock T; Lasser R; Scheckner B; Adler LA
Curr Med Res Opin; 2011 Jun; 27(6):1097-107. PubMed ID: 21438796
[TBL] [Abstract][Full Text] [Related]
32. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
[TBL] [Abstract][Full Text] [Related]
33. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
Biederman J; Pliszka SR
J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic effects of exercise-based treatment programme on children with attention-deficit/hyperactivity disorder].
Zhang J; Wen F; Zhang J; Xiao J; Zhang W; Zhou K; Chen Y
Zhonghua Er Ke Za Zhi; 2014 Apr; 52(4):287-91. PubMed ID: 24915917
[TBL] [Abstract][Full Text] [Related]
35. A compound herbal preparation (CHP) in the treatment of children with ADHD: a randomized controlled trial.
Katz M; Levine AA; Kol-Degani H; Kav-Venaki L
J Atten Disord; 2010 Nov; 14(3):281-91. PubMed ID: 20228219
[TBL] [Abstract][Full Text] [Related]
36. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
[TBL] [Abstract][Full Text] [Related]
37. A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations.
Kean JD; Downey LA; Stough C
Complement Ther Med; 2016 Dec; 29():56-62. PubMed ID: 27912958
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
[TBL] [Abstract][Full Text] [Related]
39. Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults.
Brown TE; Brams M; Gao J; Gasior M; Childress A
Postgrad Med; 2010 Sep; 122(5):7-17. PubMed ID: 20861583
[TBL] [Abstract][Full Text] [Related]
40. Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale.
Marchant BK; Reimherr FW; Robison D; Robison RJ; Wender PH
Psychol Assess; 2013 Sep; 25(3):942-50. PubMed ID: 23647041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
